A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Gao, Anqi ^a   Kantarci, Alpdogan ^a   Herrera, Bruno ^a   Gao, Hongwei ^b   Van Dyke, Thomas E ^a  

^a FORSYTH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytokine; Inflammation; Osteoblasts; Periodontitis

Indexed keywords

COLLAGENASE 3; GLYCOPROTEIN GP 130; INTERLEUKIN 10; INTERLEUKIN 6; JANUS KINASE; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 4;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

EID: 84877146467     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.51     Document Type: Article

References (44)

1. Babon JJ, Nicola NA. 2012. The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors 4:207-219 DOI 10.3109/08977194.2012.687375.
2. Barnes VM, Xu T, Shimizu E, Nakatani T, Jefcoat S, Vasilov A, Qin L, Partridge NC. 2013. Triclosan blocks Mmp 13 expression in hormone-stimulated osteoblasts. Journal of Periodontology. Epub ahead of print Jan 31, 2013 DOI 10.1902/jop.2013.
3. Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P,Marchi M, Suzuki R, Suzuki A, Yoshimura A. 1999. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94:2880-2889.
4. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. Journal of Biological Chemistry 274:10689-10692 DOI 10.1074/jbc.274.16.10689.
5. Croker BA, Kiu H, Pellegrini M, Toe J, Preston S,Metcalf D, O'Donnell JA, Cengia LH, McArthur K, Nicola NA, AlexanderWS, Roberts AW. 2012. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. Immunology and Cell Biology 90:124-129 DOI 10.1038/icb.2011.29.
6. Croker BA, Krebs DL, Zhang JG,Wormald S,Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Forster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, AlexanderWS. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nature Immunology 4:540-545 DOI 10.1038/ni931.
7. Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X,Weitzmann MN, Pacifici R. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. Journal of Clinical Investigation 117:122-132 DOI 10.1172/JCI30074.
8. Hardy R, Cooper MS. 2009. Bone loss in inflammatory disorders. Journal of Endocrinology 201:309-320 DOI 10.1677/JOE-08-0568.
9. Heeg K, Dalpke A. 2003. TLR-induced negative regulatory circuits: role of suppressor of cytokine signaling (SOCS) proteins in innate immunity. Vaccine 21(Suppl 2):S61-67 DOI 10.1016/S0264-410X(03)00202-0.
10. Inada M,Matsumoto C, Uematsu S, Akira S,Miyaura C. 2006. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. Journal of Immunology 177:1879-1885.
11. Inada M,Wang Y, Byrne MH, Rahman MU,Miyaura C, Lopez-Otin C, Krane SM. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proceedings of the National Academy of Sciences of the United States of America 101:17192-17197 DOI 10.1073/pnas.0407788101.
12. Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T. 1999. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infection and Immunity 67:2841-2846.
13. Kikuchi T,Matsuguchi T, Tsuboi N,Mitani A, Tanaka S,Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. Journal of Immunology 166:3574-3579.
14. Lang R, Pauleau AL, Parganas E, Takahashi Y,Mages J, Ihle JN, Rutschman R,Murray PJ. 2003. SOCS3 regulates the plasticity of gp130 signaling. Nature Immunology 4:546-550 DOI 10.1038/ni932.
15. Lerner UH. 2006. Bone remodeling in post-menopausal osteoporosis. Journal of Dental Research 85:584-595 DOI 10.1177/154405910608500703.
16. Liu X, Zhang Y, Yu Y, Yang X, Cao X. 2008. SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-beta1/Smad3 signaling. Molecular Immunology 45:1405-1413 DOI 10.1016/j.molimm.2007.08.018.
17. Massova I, Kotra LP, Fridman R,Mobashery S. 1998. Matrix metalloproteinases: structures, evolution, and diversification. Faseb Journal 12:1075-1095.
18. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. 1996. Bacterially induced bone destruction: mechanisms and misconceptions. Infection and Immunity 64:2371-2380.
19. Nakai K, Kawato T,Morita T, Iinuma T, Kamio N, Zhao N,Maeno M. 2012. Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts. Biochimie. Epub ahead of print Dec 28 2012 DOI 10.1016/j.biochi.2012.12.016.
20. Ohishi M,Matsumura Y, Aki D,Mashima R, Taniguchi K, Kobayashi T, Kukita T, Iwamoto Y, Yoshimura A. 2005. Suppressors of cytokine signaling-1 and-3 regulate osteoclastogenesis in the presence of inflammatory cytokines. Journal of Immunology 174:3024-3031.
21. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S,Minami A. 2002. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and-13 in rat osteoblasts. Relevance to intracellular signaling pathways. Journal of Biological Chemistry 277:7865-7874 DOI 10.1074/jbc.M106020200.
22. Orcel P, Feuga M, Bielakoff J, De Vernejoul MC. 1993. Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. American Journal of Physiology 264:E391-397.
23. Palmqvist P, Persson E, Conaway HH, Lerner UH. 2002. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. Journal of Immunology 169:3353-3362.
24. Qin H, Yeh WI, De Sarno P, Holdbrooks AT, Liu Y,Muldowney MT, Reynolds SL, Yanagisawa LL, Fox TH 3rd, Park K, Harrington LE, Raman C, Benveniste EN. 2012. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proceedings of the National Academy of Sciences of the United States of America 109:5004-5009 DOI 10.1073/pnas.1117218109.
25. Quinn CO, Scott DK, Brinckerhoff CE,Matrisian LM, Jeffrey JJ, Partridge NC. 1990. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. Journal of Biological Chemistry 265:22342-22347.
26. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA,Metcalf D, Hilton DJ, AlexanderWS. 2001. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proceedings of the National Academy of Sciences of the United States of America 98:9324-9329 DOI 10.1073/pnas.161271798.
27. Rossa C Jr., Liu M, Bronson P, Kirkwood KL. 2007. Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase. Journal of Endotoxin Research 13:85-93 DOI 10.1177/0968051907079118.
28. Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S,Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, Calcalano N, O'Garra A, Oshida T, Saito H, Johnston JA, Yoshimura A, Kubo M. 2003. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nature Medicine 9:1047-1054 DOI 10.1038/nm896.
29. Shouda T, Yoshida T, Hanada T,Wakioka T, Oishi M,Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nigata K, Yoshimura A. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. Journal of Clinical Investigation 108:1781-1788 DOI 10.1172/JCI200113568.
30. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P,Werb Z. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883-5895 DOI 10.1242/dev.01461.
31. Takami M, Kim N, Rho J, Choi Y. 2002. Stimulation by toll-like receptors inhibits osteoclast differentiation. Journal of Immunology 169:1516-1523.
32. Tardif G, Reboul P, Pelletier JP, Martel-Pelletier J. 2004. Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Modern Rheumatology 14:197-204 DOI 10.1007/s10165-004-0292-7.
33. Van De Loo FA, Veenbergen S, Van Den Brand B, Bennink MB, Blaney-Davidson E, Arntz OJ, Van Beuningen HM, Van Der Kraan PM, Van Den Berg WB. 2012. Enhanced suppressor of cytokine signaling (SOCS)-3 in arthritic cartilage dysregulates human chondrocyte function. Arthritis and Rheumatism 64:3313-3323 DOI 10.1002/art.34529.
34. Van De Loo FA, Veenbergen S, Van Den Brand B, Bennink MB, Blaney-Davidson E, Arntz OJ, Van Beuningen HM, Van Der Kraan PM, Van Den Berg WB. 2012. Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function. Arthritis and Rheumatism 64:3313-3323 DOI 10.1002/art.34529.
35. Veenbergen S, Bennink MB, de Hooge AS, Arntz OJ, Smeets RL, Van Den Berg WB, Van De Loo FA. 2008. Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis. Arthritis and Rheumatism 58:3742-3752 DOI 10.1002/art.24072.
36. Woessner JF Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Faseb Journal 5:2145-2154.
37. Wong PK, Egan PJ, Croker BA, O'Donnell K, Sims NA, Drake S, Kiu H,McManus EJ, Alexander WS, Roberts AW,Wicks IP. 2006. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. Journal of Clinical Investigation 116:1571-1581 DOI 10.1172/JCI25660.
38. Xing Q, de Vos P, Faas MM, Ye Q, Ren Y. 2011. LPS promotes pre-osteoclast activity by up-regulating CXCR4 via TLR-4. Journal of Dental Research 90:157-162 DOI 10.1177/0022034510379019.
39. Yan C, Cao J,Wu M, Zhang W, Jiang T, Yoshimura A, Gao H. 2010. Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein fbetag activity. Journal of Biological Chemistry 285:37227-37239 DOI 10.1074/jbc.M110.132084.
40. Yasukawa H, Ohishi M,Mori H,Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A. 2003. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nature Immunology 4:551-556 DOI 10.1038/ni938.
41. Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J. 2004. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. Journal of Bone and Mineral Research 19:1905-1916 DOI 10.1359/JBMR.040919.
42. Yoshimura A. 2009. Regulation of cytokine signaling by the SOCS and Spred family proteins. Keio Journal of Medicine 58:73-83 DOI 10.2302/kjm.58.73.
43. Zhang J, Zhu QL, Huang P, Yu Q,Wang ZH, Cooper PR, Smith AJ, He W. 2012. CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-kappaB signalling pathways in odontoblast cells. International Endodontic Journal, early view. Epub ahead of print 21 Jan 2013 DOI 10.1111/iej.12043.
44. Zhuang L, Jung JY,Wang EW, Houlihan P, Ramos L, Pashia M, Chole RA. 2007. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo. Laryngoscope 117:841-847 DOI 10.1097/MLG.0b013e318033783a.